オピオイドアンタゴニストのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Opioid Antagonist Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16268 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

オピオイドアンタゴニスト市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のオピオイドアンタゴニストの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のオピオイドアンタゴニストの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 オピオイドアンタゴニスト市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・経口、非経口 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界のオピオイドアンタゴニスト市場の主要な市場プレーヤーは以下のとおりです。 ・Indivior、Alkermes、Titan Pharmaceuticals、Opiant Pharmaceuticals、Hikma Pharmaceuticals、Orexo、Camurus、Acura Pharmaceuticals、Shionogi、BioDelivery Sciences International、Collegium Pharmaceutical、AstraZeneca 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、オピオイドアンタゴニスト製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なオピオイドアンタゴニストメーカーの企業概要、2019年～2021年までのオピオイドアンタゴニストの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なオピオイドアンタゴニストメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別オピオイドアンタゴニストの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのオピオイドアンタゴニストの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのオピオイドアンタゴニスト市場予測を収録しています。 ・第12、13、14章では、オピオイドアンタゴニストの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Indivior、Alkermes、Titan Pharmaceuticals、Opiant Pharmaceuticals、Hikma Pharmaceuticals、Orexo、Camurus、Acura Pharmaceuticals、Shionogi、BioDelivery Sciences International、Collegium Pharmaceutical、AstraZeneca ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、非経口 ・用途別分析2016年-2026年：病院、クリニック、その他 ・オピオイドアンタゴニストの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オピオイドアンタゴニストのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オピオイドアンタゴニストのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オピオイドアンタゴニストの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オピオイドアンタゴニストの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Opioid Antagonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Opioid Antagonist size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Opioid Antagonist market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Opioid Antagonist market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Parenteral

Market segment by Application can be divided into
Hospitals
Clinics
Others

The key market players for global Opioid Antagonist market are listed below:
Indivior
Alkermes
Titan Pharmaceuticals
Opiant Pharmaceuticals
Hikma Pharmaceuticals
Orexo
Camurus
Acura Pharmaceuticals
Shionogi
BioDelivery Sciences International
Collegium Pharmaceutical
AstraZeneca

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Opioid Antagonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Antagonist, with price, sales, revenue and global market share of Opioid Antagonist from 2019 to 2021.
Chapter 3, the Opioid Antagonist competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Antagonist breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Opioid Antagonist market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Opioid Antagonist sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Opioid Antagonist Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioid Antagonist Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral
1.2.3 Parenteral
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioid Antagonist Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Opioid Antagonist Market Size & Forecast
1.4.1 Global Opioid Antagonist Sales in Value (2016-2026))
1.4.2 Global Opioid Antagonist Sales in Volume (2016-2026)
1.4.3 Global Opioid Antagonist Price by Type (2016-2026) & (US$/Unit)
1.5 Global Opioid Antagonist Production Capacity Analysis
1.5.1 Global Opioid Antagonist Total Production Capacity (2016-2026)
1.5.2 Global Opioid Antagonist Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioid Antagonist Market Drivers
1.6.2 Opioid Antagonist Market Restraints
1.6.3 Opioid Antagonist Trends Analysis
2 Manufacturers Profiles
2.1 Indivior
2.1.1 Indivior Details
2.1.2 Indivior Major Business
2.1.3 Indivior Opioid Antagonist Product and Services
2.1.4 Indivior Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Alkermes
2.2.1 Alkermes Details
2.2.2 Alkermes Major Business
2.2.3 Alkermes Opioid Antagonist Product and Services
2.2.4 Alkermes Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Titan Pharmaceuticals
2.3.1 Titan Pharmaceuticals Details
2.3.2 Titan Pharmaceuticals Major Business
2.3.3 Titan Pharmaceuticals Opioid Antagonist Product and Services
2.3.4 Titan Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Opiant Pharmaceuticals
2.4.1 Opiant Pharmaceuticals Details
2.4.2 Opiant Pharmaceuticals Major Business
2.4.3 Opiant Pharmaceuticals Opioid Antagonist Product and Services
2.4.4 Opiant Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Hikma Pharmaceuticals
2.5.1 Hikma Pharmaceuticals Details
2.5.2 Hikma Pharmaceuticals Major Business
2.5.3 Hikma Pharmaceuticals Opioid Antagonist Product and Services
2.5.4 Hikma Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Orexo
2.6.1 Orexo Details
2.6.2 Orexo Major Business
2.6.3 Orexo Opioid Antagonist Product and Services
2.6.4 Orexo Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Camurus
2.7.1 Camurus Details
2.7.2 Camurus Major Business
2.7.3 Camurus Opioid Antagonist Product and Services
2.7.4 Camurus Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Acura Pharmaceuticals
2.8.1 Acura Pharmaceuticals Details
2.8.2 Acura Pharmaceuticals Major Business
2.8.3 Acura Pharmaceuticals Opioid Antagonist Product and Services
2.8.4 Acura Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Shionogi
2.9.1 Shionogi Details
2.9.2 Shionogi Major Business
2.9.3 Shionogi Opioid Antagonist Product and Services
2.9.4 Shionogi Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 BioDelivery Sciences International
2.10.1 BioDelivery Sciences International Details
2.10.2 BioDelivery Sciences International Major Business
2.10.3 BioDelivery Sciences International Opioid Antagonist Product and Services
2.10.4 BioDelivery Sciences International Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Collegium Pharmaceutical
2.11.1 Collegium Pharmaceutical Details
2.11.2 Collegium Pharmaceutical Major Business
2.11.3 Collegium Pharmaceutical Opioid Antagonist Product and Services
2.11.4 Collegium Pharmaceutical Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 AstraZeneca
2.12.1 AstraZeneca Details
2.12.2 AstraZeneca Major Business
2.12.3 AstraZeneca Opioid Antagonist Product and Services
2.12.4 AstraZeneca Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Opioid Antagonist Sales by Manufacturer
3.1 Global Opioid Antagonist Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Opioid Antagonist Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Opioid Antagonist
3.4 Market Concentration Rate
3.4.1 Top 3 Opioid Antagonist Manufacturer Market Share
3.4.2 Top 6 Opioid Antagonist Manufacturer Market Share
3.5 Global Opioid Antagonist Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Opioid Antagonist Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioid Antagonist Market Size by Region
4.1.1 Global Opioid Antagonist Sales in Volume by Region (2016-2026)
4.1.2 Global Opioid Antagonist Revenue by Region (2016-2026)
4.2 North America Opioid Antagonist Revenue (2016-2026)
4.3 Europe Opioid Antagonist Revenue (2016-2026)
4.4 Asia-Pacific Opioid Antagonist Revenue (2016-2026)
4.5 South America Opioid Antagonist Revenue (2016-2026)
4.6 Middle East and Africa Opioid Antagonist Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Opioid Antagonist Sales in Volume by Type (2016-2026)
5.2 Global Opioid Antagonist Revenue by Type (2016-2026)
5.3 Global Opioid Antagonist Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Opioid Antagonist Sales in Volume by Application (2016-2026)
6.2 Global Opioid Antagonist Revenue by Application (2016-2026)
6.3 Global Opioid Antagonist Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Opioid Antagonist Sales by Type (2016-2026)
7.2 North America Opioid Antagonist Sales by Application (2016-2026)
7.3 North America Opioid Antagonist Market Size by Country
7.3.1 North America Opioid Antagonist Sales in Volume by Country (2016-2026)
7.3.2 North America Opioid Antagonist Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioid Antagonist Sales by Type (2016-2026)
8.2 Europe Opioid Antagonist Sales by Application (2016-2026)
8.3 Europe Opioid Antagonist Market Size by Country
8.3.1 Europe Opioid Antagonist Sales in Volume by Country (2016-2026)
8.3.2 Europe Opioid Antagonist Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Opioid Antagonist Sales by Type (2016-2026)
9.2 Asia-Pacific Opioid Antagonist Sales by Application (2016-2026)
9.3 Asia-Pacific Opioid Antagonist Market Size by Region
9.3.1 Asia-Pacific Opioid Antagonist Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Opioid Antagonist Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Opioid Antagonist Sales by Type (2016-2026)
10.2 South America Opioid Antagonist Sales by Application (2016-2026)
10.3 South America Opioid Antagonist Market Size by Country
10.3.1 South America Opioid Antagonist Sales in Volume by Country (2016-2026)
10.3.2 South America Opioid Antagonist Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioid Antagonist Sales by Type (2016-2026)
11.2 Middle East & Africa Opioid Antagonist Sales by Application (2016-2026)
11.3 Middle East & Africa Opioid Antagonist Market Size by Country
11.3.1 Middle East & Africa Opioid Antagonist Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Opioid Antagonist Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Opioid Antagonist Typical Distributors
12.3 Opioid Antagonist Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Opioid Antagonist Revenue by Type, (USD Million), 2021-2026
Table 2. Global Opioid Antagonist Revenue by Application, (USD Million), 2021-2026
Table 3. Indivior Basic Information, Manufacturing Base and Competitors
Table 4. Indivior Major Business
Table 5. Indivior Opioid Antagonist Product and Services
Table 6. Indivior Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Alkermes Basic Information, Manufacturing Base and Competitors
Table 8. Alkermes Major Business
Table 9. Alkermes Opioid Antagonist Product and Services
Table 10. Alkermes Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Titan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Titan Pharmaceuticals Major Business
Table 13. Titan Pharmaceuticals Opioid Antagonist Product and Services
Table 14. Titan Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Opiant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Opiant Pharmaceuticals Major Business
Table 17. Opiant Pharmaceuticals Opioid Antagonist Product and Services
Table 18. Opiant Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Hikma Pharmaceuticals Major Business
Table 21. Hikma Pharmaceuticals Opioid Antagonist Product and Services
Table 22. Hikma Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Orexo Basic Information, Manufacturing Base and Competitors
Table 24. Orexo Major Business
Table 25. Orexo Opioid Antagonist Product and Services
Table 26. Orexo Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Camurus Basic Information, Manufacturing Base and Competitors
Table 28. Camurus Major Business
Table 29. Camurus Opioid Antagonist Product and Services
Table 30. Camurus Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Acura Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Acura Pharmaceuticals Major Business
Table 33. Acura Pharmaceuticals Opioid Antagonist Product and Services
Table 34. Acura Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Shionogi Basic Information, Manufacturing Base and Competitors
Table 36. Shionogi Major Business
Table 37. Shionogi Opioid Antagonist Product and Services
Table 38. Shionogi Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. BioDelivery Sciences International Basic Information, Manufacturing Base and Competitors
Table 40. BioDelivery Sciences International Major Business
Table 41. BioDelivery Sciences International Opioid Antagonist Product and Services
Table 42. BioDelivery Sciences International Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Collegium Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Collegium Pharmaceutical Major Business
Table 45. Collegium Pharmaceutical Opioid Antagonist Product and Services
Table 46. Collegium Pharmaceutical Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 48. AstraZeneca Major Business
Table 49. AstraZeneca Opioid Antagonist Product and Services
Table 50. AstraZeneca Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Opioid Antagonist Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Opioid Antagonist Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Opioid Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Opioid Antagonist Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Opioid Antagonist Production Site of Key Manufacturer
Table 56. Opioid Antagonist New Entrant and Capacity Expansion Plans
Table 57. Opioid Antagonist Mergers & Acquisitions in the Past Five Years
Table 58. Global Opioid Antagonist Sales by Region (2016-2021e) & (K Units)
Table 59. Global Opioid Antagonist Sales by Region (2021-2026) & (K Units)
Table 60. Global Opioid Antagonist Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Opioid Antagonist Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Opioid Antagonist Sales by Type (2016-2021e) & (K Units)
Table 63. Global Opioid Antagonist Sales by Type (2021-2026) & (K Units)
Table 64. Global Opioid Antagonist Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Opioid Antagonist Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Opioid Antagonist Price by Type (2016-2021e) & (US$/Unit)
Table 67. Global Opioid Antagonist Price by Type (2021-2026) & (US$/Unit)
Table 68. Global Opioid Antagonist Sales by Application (2016-2021e) & (K Units)
Table 69. Global Opioid Antagonist Sales by Application (2021-2026) & (K Units)
Table 70. Global Opioid Antagonist Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Opioid Antagonist Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Opioid Antagonist Price by Application (2016-2021e) & (US$/Unit)
Table 73. Global Opioid Antagonist Price by Application (2021-2026) & (US$/Unit)
Table 74. North America Opioid Antagonist Sales by Country (2016-2021e) & (K Units)
Table 75. North America Opioid Antagonist Sales by Country (2021-2026) & (K Units)
Table 76. North America Opioid Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Opioid Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Opioid Antagonist Sales by Type (2016-2021e) & (K Units)
Table 79. North America Opioid Antagonist Sales by Type (2021-2026) & (K Units)
Table 80. North America Opioid Antagonist Sales by Application (2016-2021e) & (K Units)
Table 81. North America Opioid Antagonist Sales by Application (2021-2026) & (K Units)
Table 82. Europe Opioid Antagonist Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Opioid Antagonist Sales by Country (2021-2026) & (K Units)
Table 84. Europe Opioid Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Opioid Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Opioid Antagonist Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Opioid Antagonist Sales by Type (2021-2026) & (K Units)
Table 88. Europe Opioid Antagonist Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Opioid Antagonist Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Opioid Antagonist Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Opioid Antagonist Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Opioid Antagonist Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Opioid Antagonist Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Opioid Antagonist Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Opioid Antagonist Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Opioid Antagonist Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Opioid Antagonist Sales by Application (2021-2026) & (K Units)
Table 98. South America Opioid Antagonist Sales by Country (2016-2021e) & (K Units)
Table 99. South America Opioid Antagonist Sales by Country (2021-2026) & (K Units)
Table 100. South America Opioid Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Opioid Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Opioid Antagonist Sales by Type (2016-2021e) & (K Units)
Table 103. South America Opioid Antagonist Sales by Type (2021-2026) & (K Units)
Table 104. South America Opioid Antagonist Sales by Application (2016-2021e) & (K Units)
Table 105. South America Opioid Antagonist Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Opioid Antagonist Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Opioid Antagonist Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Opioid Antagonist Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Opioid Antagonist Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Opioid Antagonist Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Opioid Antagonist Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Opioid Antagonist Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Opioid Antagonist Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Opioid Antagonist Typical Distributors
Table 117. Opioid Antagonist Typical Customers
List of Figures
Figure 1. Opioid Antagonist Picture
Figure 2. Global Opioid Antagonist Sales Market Share by Type in 2020
Figure 3. Oral
Figure 4. Parenteral
Figure 5. Global Opioid Antagonist Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Opioid Antagonist Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Opioid Antagonist Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Opioid Antagonist Sales (2016-2026) & (K Units)
Figure 12. Global Opioid Antagonist Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Opioid Antagonist Production Capacity (2016-2026) & (K Units)
Figure 14. Global Opioid Antagonist Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Opioid Antagonist Market Drivers
Figure 16. Opioid Antagonist Market Restraints
Figure 17. Opioid Antagonist Market Trends
Figure 18. Global Opioid Antagonist Sales Market Share by Manufacturer in 2020
Figure 19. Global Opioid Antagonist Revenue Market Share by Manufacturer in 2020
Figure 20. Opioid Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Opioid Antagonist Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Opioid Antagonist Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Opioid Antagonist Sales Market Share by Region (2016-2026)
Figure 24. Global Opioid Antagonist Revenue Market Share by Region (2016-2026)
Figure 25. North America Opioid Antagonist Revenue (2016-2026) & (USD Million)
Figure 26. Europe Opioid Antagonist Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Opioid Antagonist Revenue (2016-2026) & (USD Million)
Figure 28. South America Opioid Antagonist Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Opioid Antagonist Revenue (2016-2026) & (USD Million)
Figure 30. Global Opioid Antagonist Sales Market Share by Type (2016-2026)
Figure 31. Global Opioid Antagonist Revenue Market Share by Type (2016-2026)
Figure 32. Global Opioid Antagonist Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Opioid Antagonist Sales Market Share by Application (2016-2026)
Figure 34. Global Opioid Antagonist Revenue Market Share by Application (2016-2026)
Figure 35. Global Opioid Antagonist Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Opioid Antagonist Sales Market Share by Type (2016-2026)
Figure 37. North America Opioid Antagonist Sales Market Share by Application (2016-2026)
Figure 38. North America Opioid Antagonist Sales Market Share by Country (2016-2026)
Figure 39. North America Opioid Antagonist Revenue Market Share by Country (2016-2026)
Figure 40. United States Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Opioid Antagonist Sales Market Share by Type (2016-2026)
Figure 44. Europe Opioid Antagonist Sales Market Share by Application (2016-2026)
Figure 45. Europe Opioid Antagonist Sales Market Share by Country (2016-2026)
Figure 46. Europe Opioid Antagonist Revenue Market Share by Country (2016-2026)
Figure 47. Germany Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Opioid Antagonist Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Opioid Antagonist Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Opioid Antagonist Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Opioid Antagonist Revenue Market Share by Region (2016-2026)
Figure 56. China Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Opioid Antagonist Sales Market Share by Type (2016-2026)
Figure 63. South America Opioid Antagonist Sales Market Share by Application (2016-2026)
Figure 64. South America Opioid Antagonist Sales Market Share by Country (2016-2026)
Figure 65. South America Opioid Antagonist Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Opioid Antagonist Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Opioid Antagonist Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Opioid Antagonist Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Opioid Antagonist Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Opioid Antagonist Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---